Equities

Guangdong Marubi Biotechnology Co Ltd

603983:SHH

Guangdong Marubi Biotechnology Co Ltd

Actions
Consumer DiscretionaryPersonal Goods
  • Price (CNY)29.45
  • Today's Change1.33 / 4.73%
  • Shares traded3.57m
  • 1 Year change-13.61%
  • Beta0.8117
Data delayed at least 15 minutes, as of Apr 23 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Guangdong Marubi Biotechnology Co., Ltd is a China-based company mainly engaged in development and manufacture, design, production and sales of various cosmetics, as well as the provision of related services. The Company's products mainly include eye care products, skin cleansing products, skin care products (cream lotion and mask), make-up products and others. The Company's brands mainly include Maru, Cac and Passional Lover. The Company mainly conducts its businesses in domestic market.

  • Revenue in CNY (TTM)2.12bn
  • Net income in CNY228.00m
  • Incorporated2002
  • Employees1.06k
  • Location
    Guangdong Marubi Biotechnology Co LtdNo.11 Xicun RoadZhujiang New City, Tianhe DistrictGUANGZHOU 510000ChinaCHN
  • Phone+86 2 066378685
  • Fax+86 2 066378600
  • Websitehttp://www.marubi.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hangzhou Haoyue Personal Care Co Ltd2.76bn438.60m6.85bn1.60k15.472.10--2.482.852.8517.9421.020.62586.9817.831,718,771.009.9613.7813.5118.3426.2128.3315.9117.041.94--0.186324.02-1.6213.723.7218.8310.44--
Runben Biotechnology Co Ltd998.46m209.30m6.98bn788.0033.367.72--6.990.51730.51732.472.24------1,267,077.00--------54.89--20.96--7.32--0.0049--47.06--32.66------
Zhongnongfa Seed Industry Group Co Ltd6.76bn127.01m7.26bn1.18k57.163.90--1.070.11740.11746.251.721.537.7425.305,729,469.004.903.929.977.758.288.033.202.831.86--0.15360.0028.8214.43-44.7931.996.41--
Guangdong Marubi Biotechnology Co Ltd2.12bn228.00m11.28bn1.06k49.543.46--5.310.56760.56765.298.130.54384.2753.542,004,207.005.8111.267.0514.5369.2266.5610.6820.802.66--0.0736---3.105.07-29.74-11.0076.97--
Shanghai Jahwa United Co Ltd6.60bn500.05m12.30bn4.82k24.471.59--1.860.74330.74339.8111.440.54983.235.291,367,662.004.174.515.686.1358.2758.497.587.251.69--0.105232.68-7.16-1.565.93-1.54-20.81-1.65
Data as of Apr 23 2024. Currency figures normalised to Guangdong Marubi Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.01%Per cent of shares held by top holders
HolderShares% Held
Fullgoal Fund Management Co., Ltd.as of 30 Sep 202310.08m2.51%
Guotai Asset Management Co., Ltd.as of 30 Sep 20233.07m0.76%
GF Fund Management Co., Ltd.as of 30 Jun 20232.03m0.51%
Caitong Fund Management Co., Ltd.as of 30 Jun 20231.49m0.37%
China Universal Asset Management Co., Ltd.as of 30 Sep 20231.20m0.30%
China Asset Management Co., Ltd.as of 30 Jun 2023544.20k0.14%
The Vanguard Group, Inc.as of 31 Mar 2024504.00k0.13%
Wanjia Asset Management Co., Ltd.as of 30 Jun 2023502.00k0.13%
China Merchants Fund Management Co., Ltd.as of 30 Jun 2023413.80k0.10%
Qianhai Alliance Asset Management Co., Ltd.as of 30 Jun 2023258.80k0.07%
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.